Fangxi Xu

639 total citations
17 papers, 230 citations indexed

About

Fangxi Xu is a scholar working on Molecular Biology, Periodontics and Physiology. According to data from OpenAlex, Fangxi Xu has authored 17 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Periodontics and 7 papers in Physiology. Recurrent topics in Fangxi Xu's work include Oral microbiology and periodontitis research (7 papers), Gut microbiota and health (6 papers) and Salivary Gland Disorders and Functions (5 papers). Fangxi Xu is often cited by papers focused on Oral microbiology and periodontitis research (7 papers), Gut microbiota and health (6 papers) and Salivary Gland Disorders and Functions (5 papers). Fangxi Xu collaborates with scholars based in United States, China and Germany. Fangxi Xu's co-authors include Deepak Saxena, Xin Li, Scott C. Thomas, Mridula Vardhan, Xin Li, Manisha Holmes, Orrin Devinsky, Yuqi Guo, Angela R. Kamer and Smruti Pushalkar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Fangxi Xu

15 papers receiving 227 citations

Peers

Fangxi Xu
Sonender Pal Singh India
Deepak Kumar Suke India
David M. Keohane Ireland
Tetsuro Morikawa Japan
Sedigheh Bakhtiari Iran
Cláudio Corrêa Natalini Brazil
Nasir Zeeshan Bashir United Kingdom
A. Ojanotko-Harri Finland
Roumu Hu China
Sabrina Cenni Italy
Sonender Pal Singh India
Fangxi Xu
Citations per year, relative to Fangxi Xu Fangxi Xu (= 1×) peers Sonender Pal Singh

Countries citing papers authored by Fangxi Xu

Since Specialization
Citations

This map shows the geographic impact of Fangxi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangxi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangxi Xu more than expected).

Fields of papers citing papers by Fangxi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangxi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangxi Xu. The network helps show where Fangxi Xu may publish in the future.

Co-authorship network of co-authors of Fangxi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangxi Xu. A scholar is included among the top collaborators of Fangxi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangxi Xu. Fangxi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Xu, Fangxi, Yuqi Guo, Scott C. Thomas, et al.. (2025). Succinate modulates oral dysbiosis and inflammation through a succinate receptor 1 dependent mechanism in aged mice. PubMed. 17(1). 47–47. 2 indexed citations
3.
Lakemeyer, Markus, Rocco Latorre, Hannah M. Wood, et al.. (2025). A Bacteroides fragilis protease activates host PAR2 to induce intestinal pain and inflammation. Cell Host & Microbe. 33(10). 1686–1702.e11.
4.
Poudel, Sher Bahadur, Ryan Richard Ruff, Zhiming He, et al.. (2025). Canagliflozin-induced adaptive metabolism in bone. Diabetes. 74(5). 812–826. 3 indexed citations
5.
Li, Man, Qian Xie, Fangxi Xu, et al.. (2024). Screening of metal-modified biochars for practical phosphorus recovery. The Science of The Total Environment. 956. 177342–177342. 9 indexed citations
6.
Thomas, Scott C., Yuqi Guo, Fangxi Xu, Deepak Saxena, & Xin Li. (2023). A novel SUCNR1 inhibitor alleviates dysbiosis through inhibition of host responses without direct interaction with host microbiota. Molecular Oral Microbiology. 39(2). 80–90. 3 indexed citations
7.
Xu, Fangxi, Smruti Pushalkar, Ziyan Lin, et al.. (2022). Electronic cigarette use enriches periodontal pathogens. Molecular Oral Microbiology. 37(2). 63–76. 18 indexed citations
8.
Guo, Yuqi, Fangxi Xu, Scott C. Thomas, et al.. (2022). Targeting the succinate receptor effectively inhibits periodontitis. Cell Reports. 40(12). 111389–111389. 24 indexed citations
9.
Yan, Jun, Fangxi Xu, Jasmine Williams, et al.. (2022). Mouse model of NASH that replicates key features of the human disease and progresses to fibrosis stage 3. Hepatology Communications. 6(10). 2676–2688. 8 indexed citations
10.
Thomas, Scott C., Fangxi Xu, Smruti Pushalkar, et al.. (2022). Electronic Cigarette Use Promotes a Unique Periodontal Microbiome. mBio. 13(1). e0007522–e0007522. 31 indexed citations
11.
Paul, Bidisha, Maria A. Sierra, Fangxi Xu, et al.. (2021). Microbial population shift and metabolic characterization of silver diamine fluoride treatment failure on dental caries. PLoS ONE. 16(3). e0242396–e0242396. 9 indexed citations
12.
Ruff, Ryan Richard, Bidisha Paul, Maria A. Sierra, et al.. (2021). Predicting Treatment Nonresponse in Hispanic/Latino Children Receiving Silver Diamine Fluoride for Caries Arrest: A Pilot Study Using Machine Learning. SHILAP Revista de lepidopterología. 2. 695759–695759. 3 indexed citations
13.
Xu, Fangxi, et al.. (2021). Vaping, SARS-CoV-2, and Multisystem Inflammatory Syndrome: A Perfect Storm. Frontiers in Pediatrics. 9. 647925–647925. 9 indexed citations
14.
Fleisher, Kenneth E., Robert Glickman, Fangxi Xu, et al.. (2021). Protective Measures against COVID-19: Dental Practice and Infection Control. Healthcare. 9(6). 679–679. 14 indexed citations
15.
Thomas, Scott C., et al.. (2021). The Gut Microbiome, Metformin, and Aging. The Annual Review of Pharmacology and Toxicology. 62(1). 85–108. 45 indexed citations
16.
Yan, Wenbo, Yuqi Guo, Fangxi Xu, Deepak Saxena, & Xin Li. (2020). Identification of Differentially Methylated Regions Associated with a Knockout of SUV39H1 in Prostate Cancer Cells. Genes. 11(10). 1188–1188. 2 indexed citations
17.
Holmes, Manisha, Mridula Vardhan, Fangxi Xu, et al.. (2020). Cross talk between drug‐resistant epilepsy and the gut microbiome. Epilepsia. 61(12). 2619–2628. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonender Pal Singh Breakdown of academic impact, for papers by Deepak Kumar Suke Breakdown of academic impact, for papers by David M. Keohane Breakdown of academic impact, for papers by Tetsuro Morikawa Breakdown of academic impact, for papers by Sedigheh Bakhtiari Breakdown of academic impact, for papers by Cláudio Corrêa Natalini Breakdown of academic impact, for papers by Nasir Zeeshan Bashir Breakdown of academic impact, for papers by A. Ojanotko-Harri Breakdown of academic impact, for papers by Roumu Hu Breakdown of academic impact, for papers by Sabrina Cenni
Rankless by CCL
2026